Menu Back to DIA-Annual-Canadian-Meeting


The DIA Annual Canadian Meeting will deliver a comprehensive overview of the current bio-pharma and device landscape in Canada, while sharing insights into Canada’s broader role in global healthcare product development. From policy updates and priorities shared directly from Health Canada, to sessions on international work sharing and partnerships to key regulatory and clinical considerations for drugs and devices, you will have the exclusive opportunity to address the current issues and opportunities in Canada and across the globe.

Bringing together key stakeholders from the drug (innovator and generic/biosimilar)/, device and Patient Self Care industries, regulatory agencies, and academia, this meeting will discuss/analyze the relevant challenges and opportunities for professionals working in the field in Canada.

Key Takeaways from the 2018 Meeting

  • Access to Health Canada Officials
  • CADTH Participation
  • Multi-stakeholder perspectives
  • Forward-looking sessions
  • Comprehensive discussions around R2D2

Contact us

Registration Questions?

Send Email

Digital Learning Catalog

DIA Learning: eLearning Soultions